Richard Wagner, Ph.D.

Founder and Director

Dr. Wagner founded ZebiAI Therapeutics in May, 2019.  He is also the co-founder of X-Chem, 2009 and X-BODY Biosciences (sold to JUNO Therapeutics in 2015), 2008.  Additionally, he serves on the Board of Directors of Xios, Inc.  Dr. Wagner has served management roles at Gilead Sciences, Praecis Pharmaceuticals,  X-Rx, and SRU Biosystems.

Dr. Wagner received his B.S. in Biochemistry from Trinity College, where he currently serves on the Board of Trustees, and his Ph.D. in Chemistry from Brown University.

Other Team Members


Brian Goldman, Ph.D.

SVP and Chief Computation Scientist

Richard Wagner, Ph.D.

Founder and Director

Christelle Huguet, Ph.D.

Chair, Scientific Advisory Board

John Cuozzo Ph.D

SVP and Head of Drug Discovery

Ed Koval

Chief Business Officer

Brant Binder


Rafael Gomez-Bombarelli, Ph.D.

Chief Learning Officer